A causal relationship between unscheduled eicosanoid signaling and tumor development: Cancer chemoprevention by inhibitors of arachidonic acid metabolism

Toxicology

Volumn 153, Issue 1-3, 2000, Pages 11-26

  Marks, Friedrich ^a   Müller Decker, Karin ^a   Fürstenberger, Gerhard ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Arachidonic acid metabolism; Cancer; Carcinogenesis; Cellular signal processing; Chemoprevention; Eicosanoid signaling; Skin irritation

Indexed keywords

ARACHIDONIC ACID; CARCINOGEN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; FREE RADICAL; ICOSANOID; LIPOXYGENASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CARCINOGENESIS; CELL PROLIFERATION; GENE MUTATION; GENE OVEREXPRESSION; GENOTOXICITY; HUMAN; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN TOXICITY; TOXICITY TESTING;

ANIMALS; ARACHIDONIC ACID; CYCLOOXYGENASE INHIBITORS; EICOSANOIDS; HUMANS; NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0034676492     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(00)00301-2     Document Type: Article

References (97)

1. The cell as a collection of protein machines: Preparing the next generation of molecular biologists
2. Receptor and ion channel nomenclature supplement
3. Oncogene activation in chemical carcinogenesis
4. Regulation and inhibition of phospholipase A2
5. Keratinocytes as initiators of inflammation
6. Calcium - A life and death signal
7. Protein molecules as computational elements in living cells
8. Importance of genetic alterations in tumour development
9. Activation of Ras signaling induces the expression of human 12-lipoxygenase in A431 cell. Prostaglandins
10. Dissection of protein kinase cascades that mediate cellular response to cytokines and cellular stress
11. Adenylyl cyclases and the interaction between calcium and cAMP signalling
12. 4 pathway to inflammation control
13. Multistage carcinogenesis in mouse skin
14. Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro
15. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis and spontaneous squamous papillomas
16. What goes up must come down
17. Human cancer syndromes: Clues to the origin and nature of cancer
18. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
19. Entdecken und erfinden: Wie lasst sich Verstehen verstehen?
20. 2 is a ligand for the adipocyte differentiation factor PPARγ
21. Functional expression and cellular localization of a mouse epidermal lipoxygenase
22. Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin
23. Networks of intercellular communication: Eicosanoids and cytokines as mediators of the response of skin to toxicity
24. Stimulatory role of transforming growth factors in multistage skin carcinogenesis: Possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skin
25. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: Role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion)
26. Biological properties of 12(S)-HETE in cancer metastasis
27. Kinases and phosphatases - A marriage is consummated
28. Prostaglandin synthase 2
29. Solid-state protein networks
30. Evidence for autocrine/paracrine growth stimulation by transforming growth factor-alpha during the process of skin tumor promotion
31. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
32. Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C
33. Murine epidermal lipoxygenase (Aloxe) encodes a novel 12-lipoxygenase form
34. cDNA cloning, genomic structure, and chromosomal localization of a novel murine epidermis-type lipoxygenase
35. Lessons from hereditary colorectal cancer
36. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
37. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
38. 12-Lipoxygenase isoenzymes in mouse skin tumor development
39. cDNA cloning of a 8-lipoxygenase and a novel epidermis-type lipoxygenase from phorbol ester-treated mouse skin
40. Murine 12(R)-lipoxygenase: Functional expression, genomic structure and chromosomal localization
41. The activated keratinocyte: A model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses
42. Signal transduction through MAPkinase cascades
43. cPLA2 is phosphorylated and activated by MAPkinase
44. Deletion and altered regulation of p16 (INK4a) and p15 (INK4b) in undifferentiated mouse skin tumors
45. 12(S)-Hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase Cα in melanoma cells: Role of receptor-mediated hydrolysis of inositol phospholipids
46. Cancer cells exhibit a mutator phenotype
47. The network of intracellular signal processing as a main site of cellular responses in toxicity
48. The brain of the cell
49. Arachidonic acid and companions: An abundant source of biological signals
50. The conversion stage of skin carcinogenesis
51. Tumor promotion in skin
52. Eicosanoids and cancer
53. Cancer chemoprevention through interruption of multistage carcinogenesis: The lessons learned by comparing mouse skin carcinogenesis and human large bowel cancer
54. Protein kinase C and skin tumor promotion
55. Mechanisms in tumor promotion: Guidance for risk assessment and cancer chemoprevention
56. Aspirin and the potential role of prostaglandins in colon cancer
57. Generation of mutagens during arachidonic acid metabolism
58. Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer
59. Cyclooxygenase-2 inhibitors: Discovery, selectivity and the future
60. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
61. Regulation and function of the JNK subgroup of MAPkinases
62. Keratinocyte-derived proinflammatory key mediators and cell viability as in vitro parameters of irritancy: A possible alternative to the draize skin irritation test
63. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis
64. Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants
65. Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: Suppression of skin tumor promotion by inhibition of prostaglandin H synthase 2
66. Role of bile acids in colorectal carcinogenesis
67. Promutagenic etheno-DNA adducts in multistage mouse skin carcinogenesis: Correlation with lipoxygenase-catalyzed arachidonic acid metabolism
68. Suppression of intestinal polyp development by Nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice
69. Raf protein serine/threonine kinases
70. Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma
71. Pracarcinomatose Krankheiten und kunstliche Krebse
72. 716 knockout mice by inhibition of cyclooxygenase-2
73. Signal transduction schemes of bacteria
74. Stress-activated protein kinases: Activation, regulation and function
75. Signaling networks - Do all roads lead to the same genes
76. Cytogenetic effects caused by phorbol ester tumor promoters in primary mouse keratinocyte cultures: Correlation with the convertogenic activity of TPA in multistage skin carcinogenesis
77. Lipoxygenase metabolites of arachidonic acid in neuronal trans-membrane signalling
78. The adenomatous polyposis coli (APC) tumor suppressor
79. Molecular mechanisms of invasion and metastasis during mouse skin tumor progression
80. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
81. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDS in colon cancer? A model reconciling the current contradiction
82. Differential expression of prostaglandin H synthase in normal and activated keratinocytes in vivo and in vitro
83. Fos is an essential component of the mammalian UV response
84. Studies of neoplasia in the Min mouse
85. Colorectal cancer and nonsteroidal anti-inflammatory drugs
86. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
87. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis
88. Regulation of transcription by MAPkinase cascades
89. Aspirin use and risk of fatal cancer
90. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin hydroperoxide synthase 2
91. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents
92. Transgenic overexpression of TGFα bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis
93. Clinical and genomic influence of Sulindac on rectal mucosa in familial adenomatous polyposis patients
94. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
95. Dihydroxy bile acids activate the transcription of cyclooxygenase-2